Preclinical In Vivo Evaluation of the Safety of a Multi-shRNA-based Gene Therapy Against HIV-1
Highly active antiretroviral therapy (HAART) has significantly improved the quality of life and the life expectancy of HIV-infected individuals. Still, drug-induced side effects and emergence of drug-resistant viral variants remain important issues that justify the exploration of alternative therape...
Saved in:
Main Authors: | Mireille Centlivre (Author), Nicolas Legrand (Author), Sofieke Klamer (Author), Ying Poi Liu (Author), Karin Jasmijn von Eije (Author), Martino Bohne (Author), Esther Siteur-van Rijnstra (Author), Kees Weijer (Author), Bianca Blom (Author), Carlijn Voermans (Author), Hergen Spits (Author), Ben Berkhout (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2013-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antithrombotic Effect of shRNA Target F12 Mediated by Adeno-Associated Virus
by: Fanfan Li, et al.
Published: (2019) -
Polyamidoamine Dendrimer Conjugates with Cyclodextrins as Novel Carriers for DNA, shRNA and siRNA
by: Hidetoshi Arima, et al.
Published: (2012) -
Deep Sequencing Insights in Therapeutic shRNA Processing and siRNA Target Cleavage Precision
by: Hubert Denise, et al.
Published: (2014) -
Promoter Targeting shRNA Suppresses HIV-1 Infection In vivo Through Transcriptional Gene Silencing
by: Kazuo Suzuki, et al.
Published: (2013) -
Designing Ago2-specific siRNA/shRNA to Avoid Competition with Endogenous miRNAs
by: Hongming Ma, et al.
Published: (2014)